(MENAFN- AFP) Anglo-Swedish pharmaceutical company AstraZeneca on Monday said it had settled a long-running patent lawsuit over its top-selling drug Crestor.AstraZeneca said in a statement that the deal would protect its sales of the anti-cholesterol drug until 2016."AstraZeneca today announced that it has entered into a settlement agreement in its US patent infringement litigation against Watson Laboratories, Inc., Actavis, Inc. (formerly known as Watson Pharmaceuticals, Inc.), and EGIS Pharmaceuticals," the company said.Crestor generated $6.25 billion of sales in 2012, down from $6.6 billion in 2011 after losing patent protection in certain regions.AstraZeneca's announcement comes after it last week said it was cutting 3,900 jobs -- in a major restructuring of the group over the next three years.The group currently employs about 57,000 staff worldwide.-- Dow Jones Newswires contributed to this story --
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.